Search by Drug Name or NDC
NDC 71336-1001-01 GIVLAARI 189 mg/mL Details
GIVLAARI 189 mg/mL
GIVLAARI is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alnylam Pharmaceuticals, Inc.. The primary component is GIVOSIRAN SODIUM.
Product Information
NDC | 71336-1001 |
---|---|
Product ID | 71336-1001_c47a10ee-f647-4319-85e9-8b7505637bde |
Associated GPIs | 85080025202020 |
GCN Sequence Number | 080500 |
GCN Sequence Number Description | givosiran sodium VIAL 189 MG/ML SUBCUT |
HIC3 | D7K |
HIC3 Description | DRUGS TO TREAT ACUTE HEPATIC PORPHYRIA (AHP) |
GCN | 47364 |
HICL Sequence Number | 046222 |
HICL Sequence Number Description | GIVOSIRAN SODIUM |
Brand/Generic | Brand |
Proprietary Name | GIVLAARI |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | givosiran sodium |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | SUBCUTANEOUS |
Active Ingredient Strength | 189 |
Active Ingredient Units | mg/mL |
Substance Name | GIVOSIRAN SODIUM |
Labeler Name | Alnylam Pharmaceuticals, Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA212194 |
Listing Certified Through | 2024-12-31 |
Package
NDC 71336-1001-01 (71336100101)
NDC Package Code | 71336-1001-1 |
---|---|
Billing NDC | 71336100101 |
Package | 1 VIAL, SINGLE-USE in 1 CARTON (71336-1001-1) / 1 mL in 1 VIAL, SINGLE-USE |
Marketing Start Date | 2019-12-12 |
NDC Exclude Flag | N |
Pricing Information | N/A |